Abstract
The SIR type models are built by a set of ordinary differential equations (ODE), which are strongly initial value dependant. To fit multiple biological data with SIR type equations requires fitting coefficients of these equations by an initial guess and applying optimization methods. These coefficients are also extremely initial value-dependent. In the vast publication of these types, we hardly see, among simple to highly complicated SIR type methods, that these methods presented more than a maximum of two biological data sets. We propose a novel method that integrates an analytical solution of the infectious population using Weibull distribution function into any SIR type models. The Weibull-SIRD method has easily fitted 4 set of COVID-19 biological data simultaneously. It is demonstrated that the Weibull-SIRD method predictions for susceptible, infected, recovered, and deceased populations from COVID-19 in Kuwait and UAE are superior compared with SIRD original ODE model. The proposed method here opens doors for new deeper studying of biological dynamic systems with realistic biological data trends than providing some complicated, cumbersome mathematical methods with little insight into biological data’s real physics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no fund
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Obuda University
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
